Clinicoeconomic burden among heart failure patients with severely reduced ejection fraction after hospital admission: HF-RESTORE
Patients with an LVEF of ≤15% had a modestly increased risk of 1-year mortality, as well as significantly higher total HF costs. Patients with HFrEF and a severely reduced LVEF continue to face an increased clinicoeconomic burden, and novel therapies to treat this unmet medical need are warranted.
Authors
- Punag Divanji (ORCID: https://orcid.org/0000-0003-2868-4144)
- Heidi Thomas May (ORCID: https://orcid.org/0000-0002-7524-5905)
- Michael Butzner (ORCID: https://orcid.org/0000-0002-6015-7910)
- Joseph B. Muhlestein (ORCID: https://orcid.org/0000-0002-3366-9857)
- Jeffrey L. Anderson (ORCID: https://orcid.org/0000-0002-0825-8685)
Institutions
- University of Utah (US)
- Intermountain Medical Center (US)
- Cytokinetics (United States) (US)
Publication Details
- Journal
- European Heart Journal - Quality of Care and Clinical Outcomes
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1093/ehjqcco/qcae081
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00